{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:51:36Z","timestamp":1790808696958,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre Poland","doi-asserted-by":"publisher","award":["2021\/43\/D\/NZ4\/00081"],"award-info":[{"award-number":["2021\/43\/D\/NZ4\/00081"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ymgme.2024.108532","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T21:07:36Z","timestamp":1720213656000},"page":"108532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metabolic aspects of glycogenolysis with special attention to McArdle disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Ewa","family":"Stefanik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Dubi\u0144ska-Magiera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Daczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Migocka-Patrza\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2024.108532_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2011.00112","article-title":"The role of skeletal muscle glycogen breakdown for regulation of insulin sensitivity by exercise","volume":"2","author":"Jensen","year":"2011","journal-title":"Front. Physiol."},{"issue":"June","key":"10.1016\/j.ymgme.2024.108532_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","article-title":"Glycogen metabolism in humans","volume":"5","author":"Adeva-Andany","year":"2016","journal-title":"BBA Clin."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0525","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.spen.2006.06.007","article-title":"Glycogen storage disease: clinical, biochemical, and molecular heterogeneity","volume":"13","author":"Shin","year":"2006","journal-title":"Semin. Pediatr. Neurol."},{"issue":"25","key":"10.1016\/j.ymgme.2024.108532_bb0135","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.3748\/wjg.v29.i25.3932","article-title":"Glycogen storage diseases: an update","volume":"29","author":"G\u00fcm\u00fc\u015f","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0325","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000354271","article-title":"Severe acute rhabdomyolysis induced by multi-agent chemotherapy for alveolar rhabdomyosarcoma in a 15-year-old female: a case report","volume":"6","author":"Matsuzaki","year":"2013","journal-title":"Case Rep. Oncol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0065","first-page":"45","article-title":"Glycogen storage diseases: diagnosis, treatment and outcome","volume":"1","author":"Chen","year":"2016","journal-title":"Transl. Sci. Rare Dis."},{"issue":"24","key":"10.1016\/j.ymgme.2024.108532_bb0190","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/atm.2018.10.59","article-title":"Glycogen metabolism and glycogen storage disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0540","first-page":"1752","article-title":"Metabolic myopathies","volume":"28","author":"Tarnopolsky","year":"2022","journal-title":"CONTINUUM"},{"issue":"R1","key":"10.1016\/j.ymgme.2024.108532_bb0205","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1093\/hmg\/ddz133","article-title":"Gene therapy for glycogen storage diseases","volume":"28","author":"Kishnani","year":"2019","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11940-017-0473-2","article-title":"Treatment opportunities in patients with metabolic myopathies","volume":"19","author":"\u00d8rngreen","year":"2017","journal-title":"Curr. Treat. Options Neurol."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0615","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1111\/febs.15648","article-title":"Beyond energy storage: roles of glycogen metabolism in health and disease","volume":"288","author":"Zhang","year":"2021","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2024.108532_bb0470","series-title":"Comprehensive Physiology","first-page":"609","article-title":"Regulation of glycogen metabolism","author":"Roach","year":"2001"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bj1630193","article-title":"The influence of lysosomes on glycogen metabolism","volume":"163","author":"Geddes","year":"1977","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/301790","article-title":"Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI","volume":"62","author":"Burwinkel","year":"1998","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0450","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1097-2765(05)00006-7","article-title":"Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic Core","volume":"6","author":"Rath","year":"2000","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0365","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0026-0495(93)90169-O","article-title":"Correlations of glycogen synthase and phosphorylase activities with glycogen concentration in human muscle biopsies. Evidence for a double-feedback mechanism regulating glycogen synthesis and breakdown","volume":"42","author":"Munger","year":"1993","journal-title":"Metab. Clin. Exp."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0050","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ymgme.2013.12.008","article-title":"Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene","volume":"111","author":"Bali","year":"2014","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2024.108532_bb0590","series-title":"Neuromuscular Disorders: Treatment and Management","first-page":"409","article-title":"22 - Treatment and management of hereditary metabolic myopathies","author":"Vorgerd","year":"2011"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0070","first-page":"1002","article-title":"Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease","volume":"41","author":"Chen","year":"1987","journal-title":"Am. J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108532_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102093","article-title":"Glycogen-autophagy: molecular machinery and cellular mechanisms of glycophagy","volume":"298","author":"Koutsifeli","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jemt.20046","article-title":"Glycogen autophagy","volume":"64","author":"Kotoulas","year":"2004","journal-title":"Microsc. Res. Tech."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0520","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00003677-200407000-00008","article-title":"Novel aspects of skeletal muscle glycogen and its regulation during rest and exercise","volume":"32","author":"Shearer","year":"2004","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0605","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0440","first-page":"45","article-title":"Role of autophagy in the pathogenesis of pompe disease","volume":"26","author":"Raben","year":"2007","journal-title":"Acta Myol."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0445","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","article-title":"Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder\u2014murine Pompe disease","volume":"6","author":"Raben","year":"2010","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0390","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1080\/15548627.2020.1802090","article-title":"Glycogen: the missing link in neuronal autophagy?","volume":"16","author":"Onkar","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.ymgme.2024.108532_bb0620","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.cca.2018.06.014","article-title":"Glycophagy: an emerging target in pathology","volume":"484","author":"Zhao","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2024.108532_bb0355","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1789395","article-title":"Muscle lipid metabolism: role of lipid droplets and perilipins","volume":"2017","author":"Morales","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0335","doi-asserted-by":"crossref","first-page":"E960","DOI":"10.1152\/ajpendo.00598.2014","article-title":"ATGL-mediated triglyceride turnover and the regulation of mitochondrial capacity in skeletal muscle","volume":"308","author":"Meex","year":"2015","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0090","doi-asserted-by":"crossref","first-page":"E1117","DOI":"10.1152\/ajpendo.00257.2014","article-title":"Effects of acute lipid overload on skeletal muscle insulin resistance, metabolic flexibility, and mitochondrial performance","volume":"307","author":"Dub\u00e9","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108532_bb0295","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2337\/diabetes.51.10.3113","article-title":"Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT\/CD36","volume":"51","author":"Luiken","year":"2002","journal-title":"Diabetes"},{"issue":"Pt 24","key":"10.1016\/j.ymgme.2024.108532_bb0185","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1113\/jphysiol.2009.180695","article-title":"Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans","volume":"587","author":"Kanaley","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.ymgme.2024.108532_bb0020","series-title":"Molecular Biology of the Cell","article-title":"How cells obtain energy from food","author":"Alberts","year":"2002"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0045","article-title":"Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the Lipidome","volume":"3","author":"d\u2019Avidgnon","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tibs.2019.01.005","article-title":"Ketoacidosis - where do the protons come from?","volume":"44","author":"Green","year":"2019","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0195","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00421-022-04935-1","article-title":"A century of exercise physiology: key concepts in regulation of glycogen metabolism in skeletal muscle","volume":"122","author":"Katz","year":"2022","journal-title":"Eur. J. Appl. Physiol."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1756285613487570","article-title":"Therapeutic advances in the management of pompe disease and other metabolic myopathies","volume":"6","author":"Angelini","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0610","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(92)90003-B","article-title":"Assignment of the human glycogen debrancher gene to chromosome 1p21","volume":"13","author":"Yang-Feng","year":"1992","journal-title":"Genomics"},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0400","doi-asserted-by":"crossref","first-page":"E1096","DOI":"10.1210\/jc.2015-1339","article-title":"Lactate and energy metabolism during exercise in patients with blocked glycogenolysis (McArdle disease)","volume":"100","author":"\u00d8rngreen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0395","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/01.wnl.0000343002.74480.e4","article-title":"Fat metabolism during exercise in patients with McArdle disease","volume":"72","author":"Orngreen","year":"2009","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2024.108532_bb0595","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1055\/s-2007-1024861","article-title":"Metabolism of branched-chain amino acids and Ammonia during exercise: clues from McArdle\u2019s disease","volume":"11","author":"Wagenmakers","year":"1990","journal-title":"Int. J. Sports Med."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0375","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ymgme.2017.11.006","article-title":"Exercising with blocked muscle glycogenolysis: adaptation in the McArdle mouse","volume":"123","author":"Nielsen","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108532_bb0285","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncpneuro0913","article-title":"McArdle disease: what do neurologists need to know?","volume":"4","author":"Lucia","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/biology3010157","article-title":"McArdle disease and exercise physiology","volume":"3","author":"Kitaoka","year":"2014","journal-title":"Biology"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0235","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnen\/nlw018","article-title":"Differential muscle involvement in mice and humans affected by McArdle disease","volume":"75","author":"Krag","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108532_bb0360","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.hlc.2012.12.004","article-title":"Unforeseen cardiac involvement in McArdle\u2019s disease","volume":"22","author":"Moustafa","year":"2013","journal-title":"Heart Lung Circul."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0495","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13023-020-01562-x","article-title":"Data from the European registry for patients with McArdle disease and other muscle Glycogenoses (EUROMAC)","volume":"15","author":"Scalco","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108532_bb0500","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.nmd.2020.04.009","article-title":"Results of an open label feasibility study of sodium valproate in people with McArdle disease","volume":"30","author":"Scalco","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2024.108532_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-024-07600-x","article-title":"Cardiac comorbidities in McArdle disease: case report and systematic review","author":"Hoxhaj","year":"2024","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0370","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1249\/MSS.0000000000000458","article-title":"Cardiorespiratory fitness, physical activity, and quality of life in patients with McArdle disease","volume":"47","author":"Mungu\u00eda-Izquierdo","year":"2015","journal-title":"Med. Sci. Sports Exerc."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108532_bb0240","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.amjcard.2012.06.020","article-title":"Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome","volume":"110","author":"Lillpopp","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0430","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1515\/CCLM.2010.231","article-title":"Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy","volume":"48","author":"Pudil","year":"2010","journal-title":"Cclm"},{"issue":"23","key":"10.1016\/j.ymgme.2024.108532_bb0075","doi-asserted-by":"crossref","first-page":"13748","DOI":"10.1074\/jbc.270.23.13748","article-title":"Chimeric muscle and brain glycogen phosphorylases define protein domains governing isozyme-specific responses to allosteric activation","volume":"270","author":"Crerar","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0505","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11064-008-9825-3","article-title":"Expression of the brain and muscle isoforms of glycogen phosphorylase in rat heart","volume":"34","author":"Schmid","year":"2009","journal-title":"Neurochem. Res."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0340","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/cells10040883","article-title":"Muscle glycogen phosphorylase and its functional partners in health and disease","volume":"10","author":"Migocka-Patrza\u0142ek","year":"2021","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0420","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/mus.24716","article-title":"Minimally symptomatic Mcardle disease, expanding the genotype-phenotype Spectrum","volume":"52","author":"Petrou","year":"2015","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0475","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1113\/JP283743","article-title":"Muscle glycogen unavailability and fat oxidation rate during exercise: insights from McArdle disease","volume":"601","author":"Rodriguez-Lopez","year":"2023","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0515","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ncl.2014.05.001","article-title":"Metabolic and mitochondrial myopathies","volume":"32","author":"Sharp","year":"2014","journal-title":"Neurol. Clin."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1113\/JP275292","article-title":"Muscle molecular adaptations to endurance exercise training are conditioned by glycogen availability: a proteomics-based analysis in the McArdle mouse model","volume":"596","author":"Fiuza-Luces","year":"2018","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0085","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/(SICI)1097-4598(199606)19:6<764::AID-MUS12>3.0.CO;2-L","article-title":"Impairment of muscle mitochondrial oxidative metabolism in McArdles\u2019s disease","volume":"19","author":"De Stefano","year":"1996","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0105","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1249\/MSS.0000000000000931","article-title":"Muscle signaling in exercise intolerance: insights from the McArdle mouse model","volume":"48","author":"Fiuza-Luces","year":"2016","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.ymgme.2024.108532_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101648","article-title":"Low aerobic capacity in McArdle disease: a role for mitochondrial network impairment?","volume":"66","author":"Villarreal-Salazar","year":"2022","journal-title":"Mol. Metab."},{"issue":"March","key":"10.1016\/j.ymgme.2024.108532_bb0100","article-title":"Hepatic mitochondrial dysfunction is a feature of glycogen storage disease type Ia (GSDIa)","volume":"7","author":"Farah","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0465","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0344-0338(80)80185-3","article-title":"Glycogenosis type I (glucose 6-phosphatase deficiency): I. Ultrastructural morphometric analysis of juvenile liver cells","volume":"167","author":"Riede","year":"1980","journal-title":"Pathol. Res. Pract."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15548627.2015.1009779","article-title":"Defects in calcium homeostasis and mitochondria can be reversed in pompe disease","volume":"11","author":"Lim","year":"2015","journal-title":"Autophagy"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0160","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2013.10.003","article-title":"Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following Notexin-induced muscle damage and regeneration in the ovine model of McArdle disease","volume":"24","author":"Howell","year":"2014","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nmd.2014.10.002","article-title":"Investigating sodium valproate as a treatment for McArdle disease in sheep","volume":"25","author":"Howell","year":"2015","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0300","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1242\/dmm.020230","article-title":"Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro","volume":"8","author":"de Luna","year":"2015","journal-title":"Dis. Model. Mech."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nmd.2007.10.006","article-title":"Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle\u2019s disease: expression and re-expression of glycogen phosphorylase","volume":"18","author":"Howell","year":"2008","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0330","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/hmg\/ddz214","article-title":"Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease","volume":"29","author":"McNamara","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0510","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","article-title":"Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency","volume":"66","author":"Schroers","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2024.108532_bb0545","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.043281","article-title":"Absence of p.R50X Pygm read-through in McArdle disease cellular models","volume":"13","author":"Tarras\u00f3","year":"2020","journal-title":"Dis. Model. Mech."},{"issue":"22","key":"10.1016\/j.ymgme.2024.108532_bb0410","article-title":"Generation of the first human in vitro model for McArdle disease based on iPSC technology","volume":"23","author":"Del Ortuno-Costela","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108532_bb0145","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \u201csecond wind\u201d and glucose-induced second \u201csecond wind\u201d in McArdle disease: oxidative mechanisms","volume":"59","author":"Haller","year":"2002","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0435","article-title":"Pharmacological and nutritional treatment for McArdle disease (glycogen storage disease type V)\u2019. Edited by Cochrane neuromuscular group","author":"Quinlivan","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0305","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/WNL.51.5.1456","article-title":"Oral branched-chain amino acids do not improve exercise capacity in McArdle disease","volume":"51","author":"MacLean","year":"1998","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ymgme.2024.108532_bb0585","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archneur.57.7.956","article-title":"Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial","volume":"57","author":"Vorgerd","year":"2000","journal-title":"Arch. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108532_bb0425","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0022-510X(90)90020-N","article-title":"Dantrolene sodium does influence the second wind phenomenon in McArdle\u2019s disease","volume":"100","author":"Poels","year":"1990","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0315","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mus.20937","article-title":"Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle\u2019s disease","volume":"37","author":"Martinuzzi","year":"2008","journal-title":"Muscle Nerve"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108532_bb0535","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0022-510X(95)00320-2","article-title":"A double blind, placebo controlled, crossover trial of d-ribose in McArdle\u2019s disease","volume":"136","author":"Steele","year":"1996","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0415","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","article-title":"A metabolic myopathy due to absence of muscle phosphorylase","volume":"30","author":"Pearson","year":"1961","journal-title":"Am. J. Med."},{"issue":"26","key":"10.1016\/j.ymgme.2024.108532_bb0580","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","article-title":"The effect of Oral sucrose on exercise tolerance in patients with McArdle\u2019s disease","volume":"349","author":"Vissing","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/archneur.65.6.786","article-title":"Effect of oral sucrose shortly before exercise on work capacity in McArdle disease","volume":"65","author":"Andersen","year":"2008","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108532_bb0310","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/acn3.50863","article-title":"No effect of triheptanoin on exercise performance in McArdle disease","volume":"6","author":"Madsen","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0030","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/archneurol.2009.93","article-title":"Effect of changes in fat availability on exercise capacity in McArdle disease","volume":"66","author":"Andersen","year":"2009","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0530","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJM198502073120607","article-title":"Myopathy in McArdle\u2019s syndrome. Improvement with a high-protein diet","volume":"312","author":"Slonim","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1600-0404.1990.tb01007.x","article-title":"Improved energy kinetics following high protein diet in McArdle\u2019s syndrome. A 31P magnetic resonance spectroscopy study","volume":"81","author":"Jensen","year":"1990","journal-title":"Acta Neurol. Scand."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/adc.2008.146548","article-title":"Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity","volume":"79","author":"Andersen","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2024.108532_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/jimd.12656","article-title":"Repeated oral sucrose dosing after the second wind is unnecessary in patients with McArdle disease: results from a randomized, placebo-controlled, double-blind, cross-over study","author":"L\u00f8kken","year":"2023","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0260","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.clnu.2023.09.006","article-title":"Can a modified ketogenic diet be a nutritional strategy for patients with McArdle disease? Results from a randomized, single-blind, placebo-controlled, cross-over study","volume":"42","author":"L\u00f8kken","year":"2023","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0270","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/nu15040843","article-title":"Patient-reported experiences with a low-carbohydrate ketogenic diet: an international survey in patients with McArdle disease","volume":"15","author":"L\u00f8kken","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0080","first-page":"748","article-title":"Depot-glucagon in the treatment of McArdle\u2019s disease","volume":"15","author":"Day","year":"1985","journal-title":"Aust. NZ J. Med."},{"key":"10.1016\/j.ymgme.2024.108532_bb0055","series-title":"Cellular Metabolism and Related Disorders","article-title":"Sports and McArdle disease (glycogen storage disease type V): danger or therapy?","author":"Bollig","year":"2020"},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0220","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.34.11.1471","article-title":"Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration","volume":"34","author":"Kono","year":"1984","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ymgme.2024.108532_bb0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.880070706","article-title":"A comparative study on glucagon effect between McArdle disease and Tarui disease","volume":"7","author":"Mineo","year":"1984","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0485","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mus.22290","article-title":"Confirmation of the efficacy of vitamin B6 supplementation for McArdle disease by follow-up muscle biopsy","volume":"45","author":"Sato","year":"2012","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0280","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.nmd.2021.10.006","article-title":"Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group","volume":"31","author":"Lucia","year":"2021","journal-title":"Neuromuscul. Disord."},{"issue":"10","key":"10.1016\/j.ymgme.2024.108532_bib621","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.3390\/nu11102296","article-title":"Ketogenic diets and excercise performance","volume":"11","author":"Harvey","year":"2019","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.ymgme.2024.108532_bb0560","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.clnu.2024.01.026","article-title":"Acute ketone supplementation in the absence of muscle glycogen utilization: insights from McArdle disease","volume":"43","author":"Valenzuela","year":"2024","journal-title":"Clin. Nutr."},{"issue":"6","key":"10.1016\/j.ymgme.2024.108532_bb0150","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/ana.20881","article-title":"Aerobic conditioning: an effective therapy in McArdle\u2019s disease","volume":"59","author":"Haller","year":"2006","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0320","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/JSM.0b013e3180f6168c","article-title":"Favorable responses to acute and chronic exercise in McArdle patients","volume":"17","author":"Mat\u00e9-Mu\u00f1oz","year":"2007","journal-title":"Clin. J. Sport Med."},{"issue":"4","key":"10.1016\/j.ymgme.2024.108532_bb0385","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1249\/MSS.0000000000000812","article-title":"Exercise and preexercise nutrition as treatment for McArdle disease","volume":"48","author":"Nogales-Gadea","year":"2016","journal-title":"Med. Sci. Sports Exerc."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108532_bb0455","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nmd.2023.05.006","article-title":"Development of Continuum of care for McArdle disease: a practical tool for clinicians and patients","volume":"33","author":"Reason","year":"2023","journal-title":"Neuromuscul. Disord."},{"issue":"11","key":"10.1016\/j.ymgme.2024.108532_bb0480","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s40279-014-0223-5","article-title":"McArdle disease: a unique study model in sports medicine","volume":"44","author":"Santalla","year":"2014","journal-title":"Sports Med."},{"issue":"8","key":"10.1016\/j.ymgme.2024.108532_bb0275","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.nmd.2007.04.006","article-title":"The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle\u2019s disease","volume":"17","author":"Lucia","year":"2007","journal-title":"Neuromuscul. Disord."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0290","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/bjsports-2012-091130","article-title":"The \u201cMcArdle paradox\u201d: exercise is a good advice for the exercise intolerant","volume":"47","author":"Lucia","year":"2013","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.ymgme.2024.108532_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105658","article-title":"The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology","volume":"118","author":"Migocka-Patrza\u0142ek","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.ymgme.2024.108532_bb0565","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s40279-021-01475-0","article-title":"Muscle glycogen metabolism and high-intensity exercise performance: a narrative review","volume":"51","author":"Vigh-Larsen","year":"2021","journal-title":"Sports Med."},{"issue":"7","key":"10.1016\/j.ymgme.2024.108532_bb0120","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrneurol.2016.75","article-title":"Skeletal muscle disorders of glycogenolysis and glycolysis","volume":"12","author":"Godfrey","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2024.108532_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurol.2022.12.004","article-title":"The new horizons for treatment of late-onset Pompe disease (LOPD)","volume":"179","author":"Gu\u00e9my","year":"2023","journal-title":"Rev. Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2024.108532_bb0200","first-page":"114","article-title":"New therapeutic approaches for Pompe disease: enzyme replacement therapy and beyond","volume":"12","author":"Kishnani","year":"2014","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/jmd2.12389","article-title":"Diagnosis and management of children with McArdle syndrome (GSD V) in New South Wales","volume":"64","author":"Adams","year":"2023","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0550","article-title":"Whole-exome sequencing detects PYGM variants in two adults with McArdle disease","volume":"8","author":"Thomas-Wilson","year":"2022","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"5","key":"10.1016\/j.ymgme.2024.108532_bb0555","doi-asserted-by":"crossref","first-page":"954","DOI":"10.3390\/genes14050954","article-title":"Metabolic myopathies in the era of next-generation sequencing","volume":"14","author":"Urtizberea","year":"2023","journal-title":"Genes"},{"issue":"2","key":"10.1016\/j.ymgme.2024.108532_bb0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/ijns6020031","article-title":"Newborn screening for Pompe disease","volume":"6","author":"Sawada","year":"2020","journal-title":"Int. J. Neonatal Screen."},{"issue":"12","key":"10.1016\/j.ymgme.2024.108532_bb0140","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/metabo12121223","article-title":"Magnetic resonance imaging and spectroscopy methods to study hepatic glucose metabolism and their applications in the healthy and diabetic liver","volume":"12","author":"Gursan","year":"2022","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.ymgme.2024.108532_bb0600","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0960-8966(03)00069-5","article-title":"Evaluation of muscle glycogen content by 13C NMR spectroscopy in adult-onset acid maltase deficiency","volume":"13","author":"Wary","year":"2003","journal-title":"Neuromuscul. Disord."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719224004165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T21:52:58Z","timestamp":1728424378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719224004165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":118,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1096719224004165"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108532","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic aspects of glycogenolysis with special attention to McArdle disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2024.108532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108532"}}